Study of ATH434 in Participants with Multiple System Atrophy
Trial details
- Registry ID
- NCT05109091
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as PBT434
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study of ATH434 in Participants with Multiple System AtrophyNCT05109091 | Alterity Therapeutics | Phase 2 | Completed | 2024-11-28Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |